Latest Period
Q2 2026
Security Snapshot
abrdn Life Sciences Investors - Common (HQL) Institutional Ownership
CUSIP: 87911K100
13F Institutional Holders and Ownership History from Q3 2014 to Q2 2026
Institutions Reporting
84
Shares (Excl. Options)
7,869,347
Price
$20.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common
- Symbol
- HQL on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 7,869,347
- Total 13F value
- $156,512,869
- Portfolio coverage rank
- 0%
- Share change
- -422,065
- Value change
- -$8,119,986
- Number of holders
- 84
- Shares outstanding
- 29,948,325
- SEC-reported price per share
- $19.44
- Insider filing price
- $19.44
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HQL - abrdn Life Sciences Investors - Common is tracked under CUSIP 87911K100.
- 84 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 87 to 84 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $135,025,487 to $156,512,869.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 84 institutions filings for Q2 2026.
Security key
87911K100
Latest holder period
Q2 2026
13F holders
84
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
HQL full holder history
abrdn Life Sciences Investors SEC filings
abrdn Life Sciences Investors insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87911K100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
HQL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FIRST TRUST PORTFOLIOS LP | 10% | +63% | $51,853,848 | +$20,500,606 | 3,021,786 | +65% | First Trust Portfolios L.P. | 28 Feb 2026 |
| Saba Capital Management, L.P. | 5% | -12% | $24,978,587 | -$3,801,582 | 1,464,161 | -13% | Saba Capital Management, L.P. | 19 Feb 2026 |
As of 30 Jun 2026, 84 institutional investors reported holding 7,869,347 shares of abrdn Life Sciences Investors - Common (HQL). This represents 26% of the company’s total 29,948,325 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 5.9% | 1,771,848 | +13% | 0% | $35,454,713 |
| Penserra Capital Management LLC | 2.8% | 838,890 | +4% | 0.13% | $16,786,000 |
| RAYMOND JAMES FINANCIAL INC | 2.3% | 689,134 | +4.2% | 0% | $13,789,574 |
| LPL Financial LLC | 1.7% | 514,161 | +7.4% | 0% | $10,288,368 |
| Allspring Global Investments Holdings, LLC | 1.5% | 455,124 | +26% | 0.01% | $9,107,031 |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1.5% | 443,041 | +3.1% | 0.27% | $8,865,250 |
| FLAGSHIP HARBOR ADVISORS, LLC | 1.3% | 400,765 | +4.7% | 0.31% | $8,019,293 |
| AMERIPRISE FINANCIAL INC | 0.65% | 195,451 | +1.9% | 0% | $3,913,082 |
| Advisors Asset Management, Inc. | 0.57% | 169,812 | +5.9% | 0.05% | $3,397,938 |
| Formidable Asset Management, LLC | 0.55% | 165,243 | +4.3% | 0.44% | $2,688,504 |
| 180 WEALTH ADVISORS, LLC | 0.51% | 152,829 | +2.2% | 0.31% | $3,058,108 |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 0.5% | 150,000 | -25% | 0.14% | $3,001,500 |
| ROYAL BANK OF CANADA | 0.42% | 124,665 | +2.8% | 0% | $2,495,000 |
| BANK OF AMERICA CORP /DE/ | 0.41% | 122,374 | +5.9% | 0% | $2,448,708 |
| Janney Montgomery Scott LLC | 0.37% | 111,730 | +22% | 0% | $2,236,000 |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 0.31% | 92,899 | +5.7% | 0.23% | $1,858,909 |
| World Investment Advisors | 0.3% | 91,016 | 0% | 0.03% | $1,480,836 |
| UHLMANN PRICE SECURITIES, LLC | 0.27% | 81,518 | +4.7% | 0.06% | $1,631,156 |
| Cambridge Investment Research Advisors, Inc. | 0.26% | 78,146 | +463% | 0% | $1,564,000 |
| Saba Capital Management, L.P. | 0.26% | 78,095 | -92% | 0.05% | $1,562,681 |
| 1607 Capital Partners, LLC | 0.26% | 76,387 | -27% | 0.13% | $1,528,504 |
| Z3 Capital Partners, LLC | 0.24% | 72,030 | +7% | 0.3% | $1,441,320 |
| Steward Partners Investment Advisory, LLC | 0.23% | 68,721 | +27% | 0.01% | $1,375,109 |
| GUGGENHEIM CAPITAL LLC | 0.22% | 67,318 | +27% | 0.01% | $1,347,034 |
| STIFEL FINANCIAL CORP | 0.2% | 60,855 | +51% | 0% | $1,217,710 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
48
Latest
Q2 2026
Rows shown
1-25 of 48
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 7,869,347 | $156,512,869 | -$8,119,986 | $20.01 | 84 |
| 2026 Q1 | 8,294,323 | $135,025,487 | -$8,265,282 | $16.27 | 87 |
| 2025 Q4 | 8,787,393 | $147,292,996 | -$7,118,516 | $16.78 | 74 |
| 2025 Q3 | 9,135,304 | $141,452,290 | -$612,075 | $15.51 | 82 |
| 2025 Q2 | 9,160,432 | $117,354,763 | +$3,718,136 | $12.81 | 75 |
| 2025 Q1 | 8,871,741 | $112,593,442 | -$7,767,200 | $12.69 | 82 |
| 2024 Q4 | 9,477,441 | $124,355,615 | -$6,077,782 | $13.12 | 72 |
| 2024 Q3 | 9,873,051 | $148,865,144 | +$3,496,897 | $15.08 | 74 |
| 2024 Q2 | 9,607,549 | $136,221,681 | +$7,416,967 | $14.17 | 75 |
| 2024 Q1 | 9,097,810 | $123,989,537 | +$15,543,590 | $13.63 | 79 |
| 2023 Q4 | 7,957,094 | $107,172,259 | +$20,629,421 | $13.46 | 79 |
| 2023 Q3 | 6,434,689 | $80,230,199 | +$11,333,847 | $12.47 | 79 |
| 2023 Q2 | 5,495,691 | $74,402,090 | +$3,747,676 | $13.54 | 78 |
| 2023 Q1 | 5,218,628 | $72,689,568 | +$181,766 | $13.93 | 78 |
| 2022 Q4 | 5,215,082 | $74,160,302 | +$13,461,137 | $14.21 | 79 |
| 2022 Q3 | 4,273,316 | $58,377,986 | +$8,412,428 | $13.66 | 59 |
| 2022 Q2 | 3,670,943 | $52,261,963 | +$42,180 | $14.23 | 63 |
| 2022 Q1 | 3,659,571 | $60,566,148 | -$3,857,113 | $16.54 | 62 |
| 2021 Q4 | 3,874,395 | $74,397,923 | -$4,344,897 | $19.23 | 62 |
| 2021 Q3 | 4,078,867 | $85,055,000 | -$6,796,791 | $20.80 | 60 |
| 2021 Q2 | 4,393,839 | $94,224,459 | -$7,765,396 | $21.44 | 62 |
| 2021 Q1 | 4,759,098 | $93,769,016 | -$3,063,175 | $19.71 | 59 |
| 2020 Q4 | 4,901,740 | $96,913,930 | +$4,277,094 | $19.75 | 61 |
| 2020 Q3 | 4,667,693 | $82,119,114 | +$2,719,515 | $17.58 | 56 |
| 2020 Q2 | 4,593,229 | $82,470,887 | +$2,418,762 | $17.96 | 65 |